William Guyer - 02 Feb 2022 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship: Chief Development Officer
Issuer ticker: CORT
Reported as of: 02 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Feb 2022, 18:41:26 UTC
Prior SEC filing: 03 Sep 2021
Next SEC filing: 15 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Joseph Douglas Lyon, Attorney-in-Fact for William Guyer

Key filing fact

William Guyer filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 11 Feb 2022.

Key facts

This page summarizes William Guyer's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 11 Feb 2022, 18:41.

Change

Previous filing in this sequence was filed on 03 Sep 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CORT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +100,000
Change %
Price: $0.000000
Shares after: 100,000
Date: 02 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $19.26
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 2, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on February 2, 2026.